Probing accessible sites for ribozymes on human acetylcholinesterase RNA

RNA

Volumn 3, Issue 4, 1997, Pages 429-437

  Birikh, Klara R ^a   Berlin, Yuri A ^c   Soreq, Hermona ^b   Eckstein, Fritz ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

cleavage site selection; hammerhead ribozyme; randomized oligodeoxynucleotide; RNase H

Indexed keywords

ACETYLCHOLINESTERASE; OLIGODEOXYNUCLEOTIDE; RIBONUCLEASE H; RIBOZYME; RNA;

ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SUBSTRATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; RNA CLEAVAGE;

ACETYLCHOLINESTERASE; ASPERGILLUS NUCLEASE S1; HUMANS; KINETICS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; RIBONUCLEASE H, CALF THYMUS; RNA PRECURSORS; RNA, CATALYTIC; RNA, DOUBLE-STRANDED; RNA, MESSENGER; SUBSTRATE SPECIFICITY;

PHASEOLUS (ANGIOSPERM); VIGNA RADIATA VAR. RADIATA;

EID: 0030952735     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Altman S. 1993. RNA enzyme-directed gene therapy. Proc Natl Acad Sci USA 90:10898-10900.
2. Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M, Soreq H. 1995. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 5:1063-1071.
3. Birikh KR, Heaton PA, Eckstein F. 1997. The hammerhead ribozyme: Structure, function and application. Eur J Biochem. Forthcoming.
4. Campbell TB, Cech T. 1995. Identification of ribozymes within a ribozyme library that efficiently cleave a long substrate RNA. RNA 1:598-609.
5. Christoffersen RE, McSwiggen J, Konings D. 1994. Application of computational technologies to ribozyme biotechnology products. J Mol Struct (Theochem) 311:273-284.
6. Crisell P, Thompson S, James W. 1993. Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. Nucleic Acids Res 21:5251-5255.
7. Dropulic B, Jeang KT. 1994. Intracellular susceptibility to ribozymes in a tethered substrate-ribozyme provirus model is not predicted by secondary structures of human immunodeficiency virus type 1 RNAs in vitro. Antisense Research and Development 4:217-221.
8. Eckstein F, Lilley DMJ, eds. 1996. Nucleic acids and molecular biology, vol 10. Catalytic RNA. Berlin: Springer.
9. Grifman M, Lev-Lehman E, Ginzberg D, Eckstein F, Zakut H, Soreq H. 1996. Potential antisense oligonucleotide therapies for neurogenerative diseases. In: Strauss M, Barranger JA, eds. Concepts in gene therapy. Berlin: Walter de Gruter. Forthcoming.
10. Hayase Y, Inoue H, Ohtsuka E. 1990. Secondary structure in formylmethionine tRNA influences the site-directed cleavage of ribonuclease H using chimeric 2′-O-methyl oligodeoxyribonucleotides. Biochemistry 29:8793-8797.
11. Heidenreich O, Benseler F, Fahrenholz A, Eckstein F. 1994. High activity and stability of hammerhead ribozymes containing 2′-modified pyrimidine nucleosides and phosphorothioates. J Biol Chem 269:2131-2138.
12. Hendrix C, Anne J, Joris B, Van Aerschot A, Herdewijn P. 1996. Selection of hammerhead ribozyme for optimum cleavage of interleukin 6 mRNA. Biochem J 314:655-661.
13. Ho SP, Britton DHO, Stone BA, Behrens DL, Leffet LM, Hobbs FW, Miller JA, Trainor GL. 1996. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res 24:1901-1907.
14. Jarvis TC, Alby LJ, Beaudry AA, Wincott FE, Beigelman L, McSwiggen JA, Usman N, Stinchcomb DT. 1996. Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA. RNA 2:419-428.
15. Karpel R, Sternfeld M, Ginzberg D, Guhl E, Graessman A, Soreq H. 1996. Overexpression of alternative human acetylcholinesterase forms modulates extensions in cultured glioma cells. J Neurochem 66:114-123.
16. Knapp G. 1989. Enzymatic approach to probing of RNA secondary and tertiary structure. Methods Enzymol 180:192-212.
17. Kronenwett R, Haas R, Sczakiel G. 1996. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes. J Mol Biol 259:632-644.
18. Lapham J, Crothers DM. 1996. RNAse H cleavage for processing of in vitro transcribed RNA for NMR studies and RNA ligation. RNA 2:289-296.
19. Layer PG, Weikert T, Alber R. 1993. Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell Tissue Res 273:219-226.
20. Lev-Lehman E, Ginzberg D, Hornreich G, Ehrlich G, Meshorer A, Eckstein F, Soreq H, Zakut H. 1994. Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo. Gene Therapy 1:127-135.
21. Lieber A, Kay MA. 1996. Adenovirus-mediated expression of ribozymes in mice. J Virol 70:3153-3158.
22. Lieber A, Strauss M. 1995. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol 15:540-551.
23. Marschall P. 1996. Inhibition der Geneexpression mit Ribozymen [dissertation]. Göttingen, Germany: Universität Göttingen.
24. Marschall P, Thomson JB, Eckstein F. 1994. Inhibition of gene expression with ribozymes. Cell Mol Neurobiol 14:523-538.
25. Patinkin D, Seidman S, Eckstein F, Benseler F, Zakut H, Soreq H. 1990. Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro. Mol Cell Biol 10:6046-6050.
26. Rittner K, Burmester C, Sczakiel G. 1993. In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. Nucleic Acids Res 21:1381-1387.
27. Rossi JJ. 1995. Controlled, targeted, intracellular expression of ribozymes: Progress and problems. Trends Biotechnol 13:301-306.
28. Sczakiel G, Nedbal W. 1995. The potential of ribozymes as antiviral agents. Trends Microbiol 3:213-217.
29. Small DH, Reed G, Whitefield B, Nurcombe V. 1995. Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture. J Neurose 15:144-151.
30. Soreq H, Ben-Aziz R, Prody CA, Seidman S, Gnatt A, Neville L, Lieman-Hurwitz J, Lev-Lehman E, Ginzberg D, Lapidot-Lifson Y, Zakut H. 1990. Molecular cloning and construction of the coding region for human acetykholinesterase reveals a G+C-rich attenuating structure. Proc Natl Acad Sci USA 87:9688-9692.
31. Soreq H, Lev-Lehman E, Patinkin D, Grifman M, Ehrlich G, Ginzberg D, Eckstein F, Zakut H. 1995. Antisense oligonucleotides suppressing expression of cholinesterase genes modulate hematopoiesis in vivo and ex vivo. In: Quinn DM, Balasubramanian AS, Doctor BP, Taylor P, eds. Enzymes of the cholinesterase family. New York: Plenum Press, pp 1-6.
32. Soreq H, Patinkin D, Lev-Lehman E, Ginzberg D, Grifman M, Eckstein F, Zakut H. 1994. Antisense oligonucleotide inhibition of acetykholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo. Proc Natl Acad Sci USA 91:7907-7911.
33. Sun LQ, Warrilow D, Wang L, Witherington C, Macpherson J, Symonds G. 1994. Ribozyme-mediated suppression of Moloney murine leukemia virus and human-immunodeficiency-virus type I replication in permissive cell lines. Proc Natl Acad Sci USA 91:9715-9719.
34. Tuschl T, Ng MMP, Pieken W, Benseler F, Eckstein F. 1993. Importance of exocyclic base functional groups of central core guanosine for hammerhead ribozyme activity. Biochemistry 32:11658-11668.
35. Xing Z, Whitton JL. 1992. Ribozymes which cleave arenavirus RNAs: Identification of susceptible target sites and inhibition by target site secondary structure. J Virol 66:1361-1369.
36. Zarinkar PP, Williamson JR. 1996. The kinetic folding pathway of the Tetrahymena ribozyme reveals possible similarities between RNA and protein folding. Nature Struct Biol 3:432-438.
37. Zuker M, Stiegler P. 1981. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res 9:133-148.